These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24912416)

  • 1. Concerning Tetsuya Ishii's article: potential impact of human mitochondrial replacement on global policy regarding germline gene modification.
    Flinter F
    Reprod Biomed Online; 2014 Aug; 29(2):270. PubMed ID: 24912416
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential impact of human mitochondrial replacement on global policy regarding germline gene modification.
    Ishii T
    Reprod Biomed Online; 2014 Aug; 29(2):150-5. PubMed ID: 24832374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International harmonization and mitochondrial replacement.
    Pennings G
    Reprod Biomed Online; 2014 Aug; 29(2):269. PubMed ID: 24912419
    [No Abstract]   [Full Text] [Related]  

  • 4. How and why mitochondrial replacement gets our vote.
    Norcross S
    Reprod Biomed Online; 2014 Aug; 29(2):267-8. PubMed ID: 24912421
    [No Abstract]   [Full Text] [Related]  

  • 5. A slippery slope to human germline modification.
    Darnovsky M
    Nature; 2013 Jul; 499(7457):127. PubMed ID: 23846625
    [No Abstract]   [Full Text] [Related]  

  • 6. Reproductive therapy: HFEA responds on germline therapy.
    Thompson P
    Nature; 2013 Aug; 500(7462):276. PubMed ID: 23955222
    [No Abstract]   [Full Text] [Related]  

  • 7. SCIENCE AND REGULATION. The FDA is prohibited from going germline.
    Cohen IG; Adashi EY
    Science; 2016 Aug; 353(6299):545-6. PubMed ID: 27493171
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicine. Mitochondrial replacement, evolution, and the clinic.
    Reinhardt K; Dowling DK; Morrow EH
    Science; 2013 Sep; 341(6152):1345-6. PubMed ID: 24052294
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicine. Transatlantic lessons in regulation of mitochondrial replacement therapy.
    Cohen IG; Savulescu J; Adashi EY
    Science; 2015 Apr; 348(6231):178-80. PubMed ID: 25859028
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversies concerning mitochondrial replacement therapy.
    Klitzman R; Toynbee M; Sauer MV
    Fertil Steril; 2015 Feb; 103(2):344-6. PubMed ID: 25455872
    [No Abstract]   [Full Text] [Related]  

  • 11. Germ-line gene therapy: making the case for embryonic mitochondrial modification.
    Bankowski BJ
    MLO Med Lab Obs; 2015 May; 47(5):30. PubMed ID: 26302544
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing Mitochondrial DNA Diseases: One Step Forward, Two Steps Back.
    Cohen IG; Adashi EY
    JAMA; 2016 Jul; 316(3):273-4. PubMed ID: 27280528
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethics of mitochondrial gene replacement: from bench to bedside.
    Bredenoord AL; Braude P
    BMJ; 2010 Nov; 341():c6021. PubMed ID: 21059727
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitochondrial replacement therapy: Cautiously replace the master manipulator.
    Gemmell N; Wolff JN
    Bioessays; 2015 Jun; 37(6):584-5. PubMed ID: 25728033
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondrial Replacement Techniques: Divergence in Global Policy.
    Schandera J; Mackey TK
    Trends Genet; 2016 Jul; 32(7):385-390. PubMed ID: 27206380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventing mitochondrial diseases?].
    Nau JY
    Rev Med Suisse; 2010 Apr; 6(246):890-1. PubMed ID: 20455390
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethics of modifying the mitochondrial genome.
    Bredenoord AL; Dondorp W; Pennings G; De Wert G
    J Med Ethics; 2011 Feb; 37(2):97-100. PubMed ID: 21071569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Nuclear Genome Transfer (So-Called Mitochondrial Replacement): Clearing the Underbrush.
    Baylis F
    Bioethics; 2017 Jan; 31(1):7-19. PubMed ID: 27973718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention to prevent transmission of mitochondrial disorders should be allowed, subject to safeguards, report says.
    Hawkes N
    BMJ; 2012 Jun; 344():e4089. PubMed ID: 22693066
    [No Abstract]   [Full Text] [Related]  

  • 20. Eliminate mitochondrial diseases by gene editing in germ-line cells and embryos.
    Wang S; Yi F; Qu J
    Protein Cell; 2015 Jul; 6(7):472-5. PubMed ID: 26081469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.